BioSpace News Archive

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today reported financial results and operational highlights for the third quarter ended September 30, 2022.

Masimo announced its financial results for the third quarter of 2022, ended October 1, 2022.

Acadia Pharmaceuticals Inc. announced that it will participate at the following upcoming investor conferences.

Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the third quarter ended September 30, 2022.

Senseonics Holdings, Inc., a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring systems for people with diabetes, reported financial results for the quarter ended September 30, 2022.

GlycoMimetics, Inc. announced that management will participate in two upcoming investor conferences.

Evolus, Inc., a performance beauty company with a customer-centric approach focused on delivering breakthrough products, reported financial results for the third quarter ended September 30, 2022 and provided a business update.

Electromed, Inc., a leader in innovative airway clearance technologies, announced financial results for the three months ended September 30, 2022.

Outset Medical, Inc., a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, reported financial results for the third quarter ended September 30, 2022.

Baudax Bio, Inc. reported financial results for the three and nine months ended September 30, 2022, updated the status of the neuromuscular blocking agent development program, provided key metrics around the ongoing commercialization of ANJESO injection, and provided an overview of other corporate and financial developments.